3GREENIZE RT, MURRAY T, BOLDEN S, et al. Cancer statistics 2000[J]. CA-Cancer J Clin, 2000, 50:7 -33.
4FOSTER BA, GINGRICH JR, KWON ED, et al. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model [ J]. Cancer Research, 1997, 57:3325 - 3330.
5GREENBERG NM, DEMAYO F, FINEGOLD M, et al. Prostate cancer in a transgenic mouse [ J ]. Proc. Natl. Acad. Sci. USA, 1995, 92:3439-3443.
6Oesterling J E, Martin S K, Bergstralh E J0 et al. The use of prostate- specific antigen in staging patients with newly diagnosed prostate cancer [ J ]. JAMA, 1993,269 ( 1 ) : 57-60.
7Stamey T A, Yang N, HayA R, et al. Prostate-specific antigen as a serum marker for adenocareinoma of the prostate [J ]. N Engl J Med, 1987,317(15) :909-916.
8Therasse P, Arbuck S G, Eisenhauer E A. New guidelines to evaluate the response to treatment in solid tumors [J]. J Natl Cancer Inst, 2000,92(3) :205-216.
9Huss W J, Maddison L A, Greenberg N M. Autochthonous mouse models for prostate cancer: past, present and future [J]. Semin Cancer Biol, 2000,11 (3) : 245-260.
10Winter S F, Cooper A B, Greenberg N M. Models of metastatic prostate cancer: a transgenic perspective [J]. Prostate Cancer Prostatic Dis, 2003,6 ( 3 ) : 204- 211.
